|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310.60 DKK | -7.56% |
|
-8.97% | -33.40% |
| 05-15 | U.S. Futures Down, European Stocks Fall | DJ |
| 05-14 | Zealand Pharma A/S commences an Equity Buyback Plan, under the authorization approved on March 26, 2026. | CI |
| Capitalization | 21.94B 3.41B 2.94B 2.69B 2.56B 4.7B 327B 4.77B 32.21B 12.47B 155B 12.81B 12.53B 542B | P/E ratio 2026 * |
14.5x | P/E ratio 2027 * | 44.2x |
|---|---|---|---|---|---|
| Enterprise value | 11.11B 1.73B 1.49B 1.36B 1.3B 2.38B 166B 2.42B 16.3B 6.31B 78.67B 6.48B 6.34B 274B | EV / Sales 2026 * |
2.52x | EV / Sales 2027 * | 2.42x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zealand Pharma A/S
| 1 day | -7.56% | ||
| 1 week | -8.97% | ||
| Current month | +3.74% | ||
| 1 month | +3.57% | ||
| 3 months | -22.29% | ||
| 6 months | -39.52% | ||
| Current year | -33.40% |
| 1 week | 310.6 |  | 360.2 |
| 1 month | 294 | | 372.3 |
| Current year | 233.5 | | 478.5 |
| 1 year | 233.5 | | 556 |
| 3 years | 212.2 | | 972 |
| 5 years | 69.55 | | 972 |
| 10 years | 69.55 | | 972 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 29/03/2022 | |
| Director of Finance/CFO | - | 31/10/2022 | |
Utpal Singh
CTO | Chief Tech/Sci/R&D Officer | - | 22/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | - | |
Kirsten Drejer
BRD | Director/Board Member | 69 | 18/04/2018 |
Leonard Kruimer
BRD | Director/Board Member | 68 | 03/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.56% | -8.97% | -22.81% | +19.28% | 3.41B | |
| -0.14% | +3.34% | +42.69% | +84.71% | 50.1B | |
| +0.12% | -3.44% | +67.99% | +49.40% | 45.82B | |
| -5.60% | +7.69% | +62.36% | +466.37% | 23.66B | |
| -2.65% | -4.86% | -3.02% | -17.01% | 22.65B | |
| +3.19% | +3.12% | +41.22% | -27.18% | 17.8B | |
| -1.66% | +2.59% | +30.04% | -41.59% | 16.08B | |
| -2.91% | -10.30% | +47.85% | +186.19% | 14.14B | |
| -7.00% | -6.69% | -26.94% | +821.86% | 13.09B | |
| +0.41% | -2.37% | +40.93% | - | 13B | |
| Average | -2.38% | -2.15% | +28.03% | +171.34% | 21.97B | |
| Weighted average by Cap. | -1.44% | -1.31% | +39.39% | +142.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.41B 685M 590M 539M 514M 943M 65.75B 959M 6.47B 2.5B 31.21B 2.57B 2.52B 109B | 4.24B 660M 568M 519M 495M 908M 63.3B 923M 6.23B 2.41B 30.05B 2.48B 2.42B 105B |
| Net income | 1.43B 222M 191M 175M 167M 306M 21.31B 311M 2.1B 811M 10.12B 834M 816M 35.25B | 394M 61.27M 52.72M 48.21M 45.99M 84.32M 5.88B 85.71M 578M 224M 2.79B 230M 225M 9.72B |
| Net Debt | -10.84B -1.69B -1.45B -1.33B -1.27B -2.32B -162B -2.36B -15.91B -6.16B -76.77B -6.33B -6.19B -267B | -11.7B -1.82B -1.57B -1.43B -1.37B -2.5B -175B -2.54B -17.17B -6.64B -82.85B -6.83B -6.68B -289B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/26 | 310.60 kr | -7.56% | 679,857 |
| 12/05/26 | 336.00 kr | -3.06% | 360,553 |
| 11/05/26 | 346.60 kr | +1.58% | 567,608 |
| 08/05/26 | 341.20 kr | -1.10% | 511,280 |
| 07/05/26 | 345.00 kr | +9.45% | 1,160,345 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZEAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition